RecruitingNot applicableNCT05693701
Multicomponent Intervention Study- Blood Donors With High Cholesterol
Studying Disorder of phospholipids, sphingolipids and fatty acids biosynthesis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Texas Southwestern Medical Center
- Principal Investigator
- Amit Khera, MDUniversity of Texas Southwestern Medical Center
- Intervention
- Implementation Strategy Bundle(behavioral)
- Enrollment
- 100 target
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2023 – 2027
Study locations (1)
- UT Southwestern Medical Center, Dallas, Texas, United States
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05693701 on ClinicalTrials.gov